News and Trends 18 Apr 2019 Hookipa’s €75M IPO to Fund Vaccines for Viral Infection and Cancer …and the first clinical trials of its cancer vaccines. Based in Vienna, Hookipa develops vaccines based on engineered viruses called arenavirus. The company programs arenaviruses to express antigens mimicking viral… April 18, 2019 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 9 Jan 2020 Emergex Vaccines Secures €10M to Advance Synthetic Vaccine Development The UK biotech Emergex Vaccines has raised over €9.9M in a Series A funding round, which will allow it to progress the development of vaccines against diseases such as dengue,… January 9, 2020 - 3 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 3 Aug 2021 Oral and Nasal Covid-19 Vaccines Hit Clinical Testing …and nasal Covid-19 vaccines: simple supply logistics. Shots in general — and especially messenger RNA vaccines, which are particularly unstable and often require deep freeze for transportation — present a… August 3, 2021 - 5 minutesmins - By Victor Kotsev Share WhatsApp Twitter Linkedin Email
In Depth 13 Aug 2025 Injecting hope into skin cancer treatment: The promise of melanoma vaccines …personalized mRNA vaccines have made great strides since COVID-19 and are now being tested as cancer vaccines, with the technology proving to be extremely promising for the treatment of melanoma. … August 13, 2025 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 27 Jun 2022 Saudi Arabia to inject $3B into vaccines and medicines industry …general, whose value exceeds $5 billion, will be implemented in several stages. This will start with vaccines and vital medicines, as the first phase will focus on localizing vaccines, plasma,… June 27, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Podcast 15 Dec 2023 Vaxxinity making vaccines to change the world …Here are some links to more articles on Vaxxinity’s pipeline, as well as other companies working on using vaccines to tackle hard-to-treat diseases. 6 new vaccines being developed for difficult-to-treat… December 15, 2023 - 7 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 29 Oct 2020 Universal Flu Vaccines Yield Second Clinical Failure This Year …of Oxford in the development of their phase III-stage Covid-19 vaccine. Universal flu vaccines are seen by many as a holy grail of flu vaccines. Current seasonal flu vaccines need… October 29, 2020 - 5 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Best in Biotech 12 Apr 2023 6 new vaccines being developed for difficult-to-treat diseases …immune response, but more recent vaccines use molecules called messenger RNA (mRNA) containing instructions that direct cells to make a protein that then triggers an immune response. And, while vaccines… April 12, 2023 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 7 Mar 2018 Oxford Keeps Growing as a Hotspot for Cancer Vaccines with New Fundraising …UK cancer vaccines company has won funding from both South Korean and Chinese investors. Conventional vaccines work by introducing a patient’s immune system to molecules found on cancer cells. Oxford… March 7, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
In Depth 13 Jun 2023 Abeta-targeting antibodies pave the way for Alzheimer’s disease vaccines …Because of their long-lasting efficacy, vaccines can be easily and rapidly administered annually or semi-annually, which is convenient and improves compliance compared to more frequent injections or infusions • Vaccines… June 13, 2023 - 7 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 28 Feb 2019 Austrian Biotech Raises €33.2M to Fund Cancer Vaccines …biotechs have turned to a different approach: mRNA-based vaccines. One of these companies, CureVac is a German biotech working on mRNA-based vaccines, and collaborating with the pharma giant Eli Lilly…. February 28, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
In Depth 30 Mar 2020 Could mRNA Vaccines Fulfill Their Potential Against Coronavirus? …vaccines made from DNA. DNA vaccines are also hot on the Covid-19 case, being developed by several companies around the world, such as the US Inovio Pharmaceuticals, which aims to… March 30, 2020 - 7 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email